ABSTRACT. The impact of varying maternal glucose concentrations on glucose uptake, transfer, and metabolism was investigated in the human placenta perfused in vitro. The rates of placental glucose uptake from the maternal perfusate and transfer to the fetal perfusate were significantly correlated with maternal glucose concentration up to 20 mM. Placental glucose utilization was also dependent upon maternal glucose concentration up to 17 mM. Between 3 and 53 mM maternal glucose, lactate production increased 3-fold while no change in oxygen consumption could be demonstrated. Correlatively, glucose storage was shown to increase dramatically above 10 mM maternal glucose. These results suggest that glucose supply to the fetus may be limited in times of maternal hypoglycemia and that placental mechanism(s) may serve to buffer glucose transfer to the fetus in conditions of hyperglycemia. Chronic changes in maternal glycemia (hypo or hyper) are known to alter fetal growth and development (1, 2). In the human, the contribution of the placenta to these perturbations is not fully understood. Although placental utilization and transfer of glucose have been studied for many years (3), data are still scarce. This is mainly due to the fact that the studies have been performed in vitro using different experimental procedures, such as placental tissue slices (4, 5), isolated microvilli (6, 7), or perfused placenta (8, 9). In some of these studies, metabolic characteristics were poorly controlled and the results displayed considerable variability. So far, most of the data concerning placental metabolism has been obtained from studies performed in vivo in the sheep (1 0-12). However, it is difficult to extrapolate the data collected in ruminant epitheliochorial placenta to the hemochorial human placenta. The present study was undertaken to determine whether changes in maternal glucose concentration could modify placental glucose metabolism and to what extent this could affect glucose supply to the fetus.
Chronic changes in maternal glycemia (hypo or hyper) are known to alter fetal growth and development (1, 2). In the human, the contribution of the placenta to these perturbations is not fully understood. Although placental utilization and transfer of glucose have been studied for many years (3) , data are still scarce. This is mainly due to the fact that the studies have been performed in vitro using different experimental procedures, such as placental tissue slices (4, 5) , isolated microvilli (6, 7), or perfused placenta (8, 9) . In some of these studies, metabolic characteristics were poorly controlled and the results displayed considerable variability. So far, most of the data concerning placental metabolism has been obtained from studies performed in vivo in the sheep (1 0-12). However, it is difficult to extrapolate the data collected in ruminant epitheliochorial placenta to the hemochorial human placenta. The present study was undertaken to determine whether changes in maternal glucose concentration could modify placental glucose metabolism and to what extent this could affect glucose supply to the fetus.
MATERIALS AND METHODS
Perfusion technique. Term human placentas were obtained from uncomplicated pregnancies after either vaginal delivery or caesarean section. The perfusion experiments were performed on an isolated lobule according to the method described by Panigel et al. (13) , recently adapted for metabolic studies (14) . medium containing bovine serum albumin (1 g/liter). The P -D ( + ) -~~u c o s~ (Sigma, St Louis, MO) concentration in medium perfusing the fetal side was fixed at 2.8 mM. Glucose concentration in medium perfusing the maternal side varied from 2.8 to 53 mM. In some experiments 3-3H-~-glucose (10 mCi/mmol, NEN, Paris, France) was added to arterial maternal perfusate to determine the diffusion rate of glucose.
Arterial perfusion fluids were continuously gassed with 95%
O2 + 5% C02. Flow rates were monitored with R2 15 A Brooks flowmeters and pressures were measured with mercury manometers (Boulitte, Paris, France) on fetal and maternal circulations.
Experimental protocol and sampling procedures. Within 30
min after delivery the main fetal artery and vein draining the selected lobule were cannulated. The experiments started 20 min after the onset of fetal perfusion when two cannulas were inserted into the intervillous space over the area blanched by perfusion of fetal circulation. The experiment lasted 120 min. Fetal and maternal fluid samples were obtained every 5 or 10 min simultaneously on arterial and venous circulations for substrate determinations and gas measurements. As shown in Table 1 , perfusion studies have been performed in a straight range of flow rates and cotyledon weights. Thus, homogenous experimental conditions were obtained between individual placentas.
Biochemical determinations. Samples for glucose and lactate determinations were collected on chilled perchloroacetic acid (6%). Substrate concentrations were measured on protein-free supernatants neutralized with KOH. Glucose was determined using glucose oxidase (God-Perid, Boehringer, Mannheim, Germany) and lactate according to the method of Hohorst (1 5). PO2 and pco, determinations were performed using a blood gas analyser (BMS 3 Mk2 Radiometer, Copenhagen, Denmark) on separate samples kept in air tight syringes at 4" C.
Data analysis. From the data collected during the steady state period of each perfusion (four to eight individual determinations), the following calculations were performed: 1) glucose uptake: maternal A-V concentration difference x flow rate; 2) glucose transfer: fetal V-A concentration difference x flow rate; 3) glucose utilization: glucose uptake-glucose transfer; 4) lactate production: maternal venous concentration x flow rate + fetal venous concentration X flow rate; 5) oxygen consumption: maternal A-V concentration difference x flow rate + fetal A-' V concentration difference x flow rate. The O2 concentration was calculated from the following relationship: PO2 x 0.0239/PB -47. PO2 represents the oxygen partial pressure (mm Hg), 0.0239 the solubility of O2 in ml/ml perfusate, PB the barometric pressure (mm Hg) and 47 the water vapor pressure (mm Hg) at 37" C.
The glucose/oxygen quotient represents the maximal quantity of glucose that could be oxidized for a given oxygen consumption. Since 6 mol of 0 2 are required to completely oxidize 1 mol of glucose to C 0 2 and H20, the glucose/oxygen quotient is 270 HAUGUEL ET AL. defined as:
Concentrations were expressed in I*mol/ml and flow rates in ml/min/g of placenta. For each compound, the results were given in I*rnol/min/g of wet cotyledon weight.
The amount of glucose contributing to lactate production can be calculated from AL/2 since the conversion of 1 mol of glucose gives 2 mol of lactate. The maximal amount of glucose oxidized was calculated as A02/6. The amount of glucose which was not accounted for lactate production and oxygen consumption was defined as the maximal capacity of the placenta to store glucose. It was calculated by subtracting the maximal rate of glucose oxidized and the rate of lactate production from total glucose utilization.
Statistical methods. All values are given as mean + SE. Linear or polynomial regression analysis using the method of least squares were used to analyze the relationships between various parameters using a Hewlett-Packard computer HP-4 1C.
RESULTS

Rate of placental glucose uptake as a function of maternofetal glucose concentration gradient.
The relationship between placental glucose uptake and maternofetal glucose gradient is shown in Figure 1A . A significant correlation ( r = 0.98, p < 0.01) was found when the data were fitted to a cubic equation (y = -0.69x3
The curve shows a saturable component at glucose gradient below 17 mM and a nonsaturable component at glucose gradient higher than 17 mM. This threshold of maternofetal gradient corresponds to a maternal glucose concentration of 20 mM.
The nonsaturable component represents simple inward diffusion of substrate. This is demonstrated in Figure 1 A where uptake of 3-3H-~-glucose is linearly correlated to glucose gradient (or Table 1 Fig. by the maternal concentration) and the straight line represents the diffusional component. When the data were corrected for glucose diffusion, a maximal rate of 1.6 I*mol/min/g was obtained for glucose uptake (Fig. 1 B) .
Rate ofplacental glzlcose transfer as a firnetion of maternofetal glucose concentration gradient. A significant correlation (r = 0.92, p < 0.01) between placental glucose transfer and maternofetal glucose gradient was obtained when the data were fitted to a cubic equation (y = -0.29x3 + 0.64x2 -0.1 1x + 0.01). As already observed for glucose uptake, the saturation started at 17 mM glucose gradient (i.e. 20 mM maternal glucose). Transfer of 3-3H-~-glucose was also linearly correlated to glucose gradient (Fig. 1A) . When the data were corrected for diffusion, the maximal rate of glucose transfer was 0.6 I*rnol/min/g (Fig. 1 B) .
Kinetic characteristics of glucose uptake and transfer. The data corrected for diffusion conform to the Michaelis-Menten equation and apparent Km values can be calculated from LineweaverBurk plots. This analysis is shown in Figure 2 . The Km values for glucose uptake and transfer were 17 and 13 mM, respectively.
Rates ofplacental glucose utilization as a function of maternal glucose concentration. The mean rate of placental glucose utilization has been calculated in each of the 10 experiments in steady state conditions. A significant correlation (y = -0.39x3 + 0.8x2 -0 . 1 2~ + 0.0 1; r = 0.96; p < 0.0 1) was observed between (---) . B, glucose uptake (0) and transfer (A) rates corrected for diffusion.
GLUCOSE DISTRIBUTION TO PERFUSED PLACENTA 27 1 placental glucose utilization and maternofetal concentration gradient using the method of least squares to calculate the regression. At maternal glucose concentration greater than 14 mM, the slope of the linear regression was not significantly different from zero ( p < 0.5), indicating a maximal rate of glucose utilization by the placenta. This rate averaged 1.05 + 0.09 pmol/min/g (Fig. 3) .
Placental oxygen consumption, lactate production, and glucoseloxygen quotients. Oxygen consumption and lactate production by the placenta were measured in the same series of experiments. Oxygen consumption (0.37 + 0.03 pmol/min/g) did not change when maternal glucose concentration increased from 3 to 5 3 mM. In contrast, lactate production increased from 0.12 + 0.03 to 0.48 + 0.01 pmol/min/g when maternal glucose rose from 3 to 5.5 mM. A mean value of 0.40 k 0.06 pmol/min/g was obtained for maternal glucose concentrations ranging between 5.5 and 53 mM. As shown in Figure 4 , the quantity of glucose that could be maximally oxidized followed the same pattern as lactate production over the range of maternal concentration from 4 to 53 mM, while glucose storage (total glucose utilization minus glucose metabolized to lactate and maximal glucose oxidized) was increased from 0 to 70% of glucose utilization.
The G / 0 2 quotients measured in each experiment are presented in Table 2 . These quotients have been corrected for lactate production and represent the maximal amount of glucose that could be oxidized per mmol of oxygen consumed by the placenta. The lowest quotient was 1.10 corresponding to 4 mM maternal glucose.
DISCUSSION
Placentalglucose uptake and transfer. The present study establishes the relationships that exist between placental glucose uptake from the maternal circulation, transfer to the fetal circulation and utilization, and maternal glucose concentration. The rates of glucose uptake and transfer were proportional to maternal glucose concentration up to 17-22 mM for a maternofetal gradient of [14] [15] [16] [17] [18] [19] mM. Above this value both glucose uptake and transfer rates appeared to be limited. Such a limitation of glucose transfer had also been reported for the human placenta in previous studies (1 6, 17) but at a much higher maternal glucose concentration than that found in the present study. The saturation begins for a maternofetal concentration gradient of [7] [8] [9] [10] MATERNAL GLUCOSE (mM) Fig. 3 . Placental glucose utilization as a function of maternal glucose concentration. In addition, mean values for saturation were obtained from two .
or three placentas only. In the present experiments, maternal glucose concentration was maintained at constant value during the whole perfusion ensuring steady state measurements. The kinetics of glucose uptake by the human placenta have never been studied previously simultaneously with glucose transfer. Our results show that the placenta has a limited capacity to take up glucose from maternal circulation and that this limitation is coupled with that of transfer. The apparent threshold of 17 mM is well above physiological glucose levels; even in diabetic pregnancies such high levels of blood glucose are rarely encountered since such patients are now generally well controlled. The data from Figure 1 show that the diffusion process was not negligible in these studies and that it represents 40% of total uptake at 53 mM maternal glucose. This is in agreement with the data provided by Schneider et al. (9) and Carstensen et al. (16) who found a diffusion of 30 and 70%, respectively, depending on the maternofetal glucose gradient. By contrast, Johnson and Smith (18) found this phenomenom to be negligible in microvillous vesicles prepared from human placenta. The rate of placental glucose transfer measured in our studies at normal maternal glucose concentration is 0.29 5 0.03 pmol/min/g placenta and corresponds to a maximal glucose utilization by the fetus of 150 pmol/min for a 500 g placenta, i.e. 43 pmol/min/ kg fetus for a 3.5 kg fetus. This value is slightly higher than the value estimated in vivo (19) of 38 pmol/min/kg fetus at a maternal glucose concentration of 5.5 mM.
Kinetic churucteristics of glucose transport. Kinetic characteristics of the glucose transport system can only be determined when total saturation is achieved, i.e. when data have been corrected for simple diffusion. Under these conditions glucose uptake and transfer have similar Km of 13-17 mM. This value is 3-fold higher than the normal maternal blood glucose concentration, indicating that the glucose transport sites are never saturated under in vivo physiological conditions and that glucose transport is not a limiting factor for glucose supply to the fetus.
To our knowledge this is the first study in which Km values were simultaneously measured for glucose uptake and transfer in conditions that conserve the cellular integrity of the placenta in contrast to the situation with microvillous preparations. Johnson and Smith (1 8) have reported a slightly higher Km value for the glucose analog, 3-0-methylglucose (24 or 3 1 + 13 mM).
More recently, these authors have demonstrated that the characteristics of the glucose transport system across the basal membrane of placental syncytium (fetal-facing) are similar to those of the microvillous membrane on the opposite side of the syncytium (maternal-facing) (7) . These data are in accord with the present results indicating that glucose transport kinetics for uptake and transfer are comparable. Similar findings have also been reported for the guinea pig placenta. Yudilevitch et al. (20) found that the glucose transport system on the maternal and the fetal sides of the trophoblast have the same kinetic characteristics, and Bissonnette (21) demonstrated a Km value of 12 mM. An equivalent observation has also been reported for the sheep placenta studied in vivo (22) . In this report the authors have made the assumption that there is a negligible glucose gradient within the cell and that the carriers on both sides of the placenta have the same Km of 3.8 mM. The maximal rate of glucose transport has also been quantified, and averages 2.2 pmol/min/g for uptake (Fig. 2) . It is two times lower than the value estimated in placental microvilli in vitro, i.e. 1.9 mmol/min for the whole placenta (6) .
Placental glucose metabolism. As observed for glucose uptake and transfer, placental glucose utilization rate is proportional to maternal glucose concentration (Fig. 3 ) until 17-22 mM and always represents 50 to 60% of total glucose uptake by the placenta. Thus, we cannot conclude from these results whether the saturation of glucose utilization above this concentration is the consequence of the limited uptake at this concentration or a concomitant limitation of several steps in the pathway of glucose utilization. The onset of saturation observed in our experiments is twice as high than that observed in other perfusion studies (8) in which the maximal rate of glucose utilization was 0.12 pmol/ min/g, i.e. a value 10-fold lower than that obtained in the present study (1.0 pmol/min/g). The placental oxygen consumption of 0.37 Fmol/min/g measured at 5.5 mM maternal glucose is two to three times lower than that reported in the sheep uteroplacenta in vivo (1 l), 0.89 pmol/min/g. However it is of the same order of magnitude of values measured in the fetoplacental unit of the rabbit (23) and the cow (24) . Although previous studies have shown that the conditions of oxygenation used in our perfusions are within the physiological range (14, 25) , we still should consider the possibility that the oxygen consumption had been physically limited in our experiments. In maternal physiological conditions (4 to 7 mM arterial glucose), the maximal proportion of glucose which is retained, but not metabolized, within the placenta is very small but increases dramatically during maternal hyperglycemia (Fig. 4) . These findings agree with the enhanced glycogen and lipid deposition found in placentas from diabetic mothers (26, 27) . The very high G/Oz quotients measured under conditions of marked hyperglycemia ( Table 2 ) also suggest that the maximal capacity of the placenta to oxidize glucose becomes rapidly saturated, as does total lactate production when maternal glucose concentration increases. The relative glucose utilization by the fetoplacental unit and GLUCOSE DISTRIBUTION TO PERFUSED PLACENTA 273 nonuterine maternal tissues can be calculated from the present in vitro data and should be regarded as only an estimation of the in vivo situation. At 5.5 mM maternal glucose, the maximal rate of glucose uptake by the placenta is 3 10 pmol/min of which 50% are readily transferred to the fetal circulation and 50% retained within the placenta (Fig. 1, Table 2 ). Using a glucose turnover rate of 880 pmollmin for a 65 kg pregnant woman at term (1 9), it can be assumed that about 35% of maternal glucose production would be diverted to the fetoplacental unit while the remaining 65% would possibly be utilized by nonuterine maternal tissues. It is of interest that this estimated value is in the range of the partition of maternal glucose production between the conceptus and nonuterine maternal tissues observed in the pregnant sheep in vivo (I I).
In conclusion, this study has demonstrated that glucose supply to the fetus is highly dependent upon maternal glycemia between 3 and 20 mM. Thus the supply of glucose to the fetus is likely to be diminished in the case of maternal hypoglycemia and to be increased in the case of maternal hyperglycemia (diabetes), conditions known to affect fetal growth. In addition, these data provide evidence suggesting that the placenta possesses a compensatory mechanism (i.e. a large capacity for glucose storage) that blunts glucose transfer to the fetus when maternal hyperglycemia prevails.
